Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765 from lymphocyte Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Dr Susan O’Brien presented data on PCI-32765 at ASH 2011 and discussed some of the details with ecancertv. Dr O’Brien explained that if the drug can ligate the B cell receptor, then this could be beneficial by preventing signals going to the cell nucleus. nn nnThe clinical relevance is that PCI-32765 targets a specific mutation in patients and rapidly reduces lymph node mass with very little toxicity and without being myelosuppressive; however, the drug increases lymphocyte count. Over tim
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)